By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cipla Ltd. 

Mumbai Central

Mumbai    400 008  India
Phone: 91-22-308-2891-or-91-22-309-5521 Fax: 91-22-307-0013



Company News
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014 10:27:48 AM
Meda And Cipla Ltd. Sue Apotex Corp. To Enforce Dymista® Patents 12/3/2014 9:06:22 AM
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS) 10/30/2014 6:26:21 AM
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014 6:16:40 AM
Cipla Ltd. And Bioquiddity Announce EU Commercial Partnership For Onedose-ReadyfusOr For Post-Surgical Pain Management 7/31/2014 9:00:51 AM
Despite Repeated Rebuffs, Teva Pharmaceutical Industries Limited (TEVA) Woos Cipla Ltd. With $6 Billion Offer 5/8/2014 6:25:06 AM
Notices Sent To Ranbaxy Laboratories (RANBAXY.BO), Cipla Ltd. For Overcharging 12/10/2013 7:48:55 AM
Meda AB (MEDA-A.ST) Expands Collaboration With the Indian Pharmaceutical Company Cipla Ltd. 6/5/2013 9:24:17 AM
Cipla Ltd. Probed for Anti-Competitive Practices 5/9/2013 7:44:13 AM
Cipla Ltd. Launches Shanghai CP Guojian's Biosimilar in India 4/19/2013 9:42:48 AM